J FrontierLtd Past Earnings Performance
Past criteria checks 0/6
J FrontierLtd's earnings have been declining at an average annual rate of -208.1%, while the Healthcare industry saw earnings growing at 6.4% annually. Revenues have been declining at an average rate of 0.8% per year.
Key information
-208.1%
Earnings growth rate
-193.6%
EPS growth rate
Healthcare Industry Growth | 7.9% |
Revenue growth rate | -0.8% |
Return on equity | -57.2% |
Net Margin | -10.1% |
Last Earnings Update | 29 Feb 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How J FrontierLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
29 Feb 24 | 17,007 | -1,710 | 9,084 | 0 |
30 Nov 23 | 15,754 | -1,836 | 9,164 | 0 |
31 Aug 23 | 15,525 | -1,800 | 9,002 | 0 |
31 May 23 | 16,844 | -1,899 | 8,631 | 0 |
28 Feb 23 | 17,148 | -555 | 6,760 | 0 |
30 Nov 22 | 17,067 | -104 | 5,735 | 0 |
31 May 22 | 11,876 | 400 | 4,608 | 0 |
Quality Earnings: 2934 is currently unprofitable.
Growing Profit Margin: 2934 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if 2934's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare 2934's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 2934 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (6.7%).
Return on Equity
High ROE: 2934 has a negative Return on Equity (-57.18%), as it is currently unprofitable.